Correction: Screen to Save: Results from NCI's Colorectal Cancer Outreach and Screening Initiative to Promote Awareness and Knowledge of Colorectal Cancer in Racial/Ethnic and Rural Populations

2022 ◽  
Vol 31 (1) ◽  
pp. 298-298
Author(s):  
Damiya E. Whitaker ◽  
Frederick R. Snyder ◽  
Sandra L. San Miguel-Majors ◽  
LeeAnn O. Bailey ◽  
Sanya A. Springfield
2020 ◽  
Vol 29 (5) ◽  
pp. 910-917 ◽  
Author(s):  
Damiya E. Whitaker ◽  
Frederick R. Snyder ◽  
Sandra L. San Miguel-Majors ◽  
LeeAnn O. Bailey ◽  
Sanya A. Springfield

2017 ◽  
Vol 15 (4) ◽  
pp. 180-188 ◽  
Author(s):  
Melissa Gonzales ◽  
Fares Qeadan ◽  
Shiraz I. Mishra ◽  
Ashwani Rajput ◽  
Richard M. Hoffman

2018 ◽  
Vol 27 (9) ◽  
pp. 1011-1018 ◽  
Author(s):  
Libby Ellis ◽  
Renata Abrahão ◽  
Meg McKinley ◽  
Juan Yang ◽  
Ma Somsouk ◽  
...  

2021 ◽  
Vol 39 (3_suppl) ◽  
pp. 21-21
Author(s):  
Michael Lyudmer ◽  
Riya Jayesh Patel ◽  
Adel Chergui ◽  
Seda Serra Tolu ◽  
Devika Rao ◽  
...  

21 Background: Globally, the incidence of early-onset colorectal cancer has risen. Racial disparities in colorectal cancer (CRC) are well-described, however data in EO by race/ethnicity is lacking. We aim to compare the presenting features, treatment, and survival features of patients with metastatic early-onset CRC (EO). Methods: Patients with metastatic CRC diagnosed between 2010-2019 at two NYC hospitals were identified by tumor registry (n = 646). Clinical/pathological features, treatment and survival data was collected by chart review and compared between Non-Hispanic Whites (NHW), Non-Hispanic Blacks (NHB) and Hispanics (H) using Chi-square or Fisher’s exact test. Kaplan Meier curves were plotted to compare overall survival (OS) among groups. Stata v15 was used for statistical analysis. Results: Of 646 CRC patients, 126 (21.5%) were NHW, NHB or H diagnosed with EO with a frequency ranging from 16.6% in NHW to 26.1% in H. Non statistically significant lower frequencies of male gender, low/moderate grade, left-sided tumors,and higher frequency of KRAS mutations were seen in NHB (Table). Metastectomy was performed in 20 patients (13.9%) and did not differ between groups. There was no difference in the use of chemotherapy or biologics in general (Table), but NHW were more likely to get cetuximab than NHB (OR:4.5, p = 0.02) and H (OR:4.7, p = 0.02).There were no differences in median OS (1.8 vs. 2.2 vs. 2 years, p = 0.9)or 1-year OS (72% vs 72.3% vs 70.8%) in NHW, NHB and H, respectively. A lower 5-year OS was seen in NBH (14.5%) and Hispanics (24.4%) compared to NHW (44%). Conclusions: EO-CRC is more frequently seen in minority racial/ethnic groups. Despite no differences in the use of chemotherapy or biologic treatment in general, NHB have a lower 5-year survival rate compared to NHW and H. [Table: see text]


2020 ◽  
Vol 72 (1) ◽  
Author(s):  
Chyke A. Doubeni ◽  
Kevin Selby ◽  
Samir Gupta

Preventable differences in colorectal cancer (CRC) mortality across racial/ethnic, economic, geographic, and other groups can be eliminated by assuring equitable access and quality across the care continuum, but few interventions have been demonstrated to do so. Multicomponent strategies designed with a health equity framework may be effective. A health equity framework takes into account social determinants of health, multilevel influences (policy, community, delivery, and individual levels), screening processes, and community engagement. Effective strategies for increasing screening uptake include patient navigation and other interventions for structural barriers, reminders and clinical decision support, and data to continuously track metrics and guide targets for improvement. Community resource gaps should be addressed to assure high-quality services irrespective of racial/ethnic and socioeconomic status. One model combines population-based proactive outreach screening with delivery screening at in-person or virtual points of contact, as well as community engagement. Patient- and provider-based behavioral interventions may be considered for increasing screening demand and delivery. Providing a choice of screening tests is recommended for CRC screening, and access to colonoscopy is required for completion of the CRC screening process. Expected final online publication date for the Annual Review of Medicine, Volume 72 is January 27, 2021. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.


2019 ◽  
Vol 10 (7) ◽  
pp. e00059 ◽  
Author(s):  
Andreana N. Holowatyj ◽  
Mark A. Lewis ◽  
Samantha T. Pannier ◽  
Anne C. Kirchhoff ◽  
Sheetal Hardikar ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document